Butylparaben is used as a preservative in cosmetics and in skin care products. Inclusion on the Candidate List will also impact on manufacturers of medical devices as specific justification and obligations to label endocrine disrupting substances may be required for the devices.
Butylparaben has been included on the Candidate List because of its endocrine disrupting effects. This means that the substance is one step closer to be included on the REACH Authorisation List. In that case the continued use of the substance will be subject to authorisation.
For an overview of endocrine disruptors in the EU including substances under evaluation for endocrine disrupting properties, visit the website recently launched by the Danish Environmental Protection Agency and four other national authorities: https://edlists.org/
For more information on endocrine disrupting chemicals, please contact:
Poul Bo Larsen
pbl@dhigroup.com
Tel +45 4516 9478
LinkedIn